05/15/2024
1:54 PM | Vivos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/14/2024
3:16 PM | Vivos Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/28/2024
11:15 PM | Vivos Therapeutics (Filer)
| Form EFFECT | |
04/19/2024
6:52 PM | Vivos Therapeutics (Filer)
| Form S-1/A | |
04/08/2024
7:22 PM | Vivos Therapeutics (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
03/28/2024
7:38 PM | Vivos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/15/2024
7:55 AM | Vivos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
02/14/2024
4:42 PM | Huntsman Ronald Kirk (Filed by)
Vivos Therapeutics (Subject)
Vivos Therapeutics (Subject)
| Form SC 13G/A | |
12/03/2023
11:15 PM | Vivos Therapeutics (Filer)
| Form EFFECT | |
11/22/2023
3:46 PM | Vivos Therapeutics (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
11/03/2023
4:00 PM | Vivos Therapeutics (Filer)
| Form 424B3 | |
10/27/2023
3:15 PM | Vivos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/25/2023
8:00 AM | Vivos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/21/2023
4:10 PM | Vivos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/14/2023
3:38 PM | Vivos Therapeutics (Filer)
| Form DEFA14A | |
09/06/2023
4:26 PM | Vivos Therapeutics (Filer)
| Form DEFA14A | |
08/28/2023
8:00 AM | Vivos Therapeutics (Filer)
| Form DEF 14A | |
08/21/2023
8:00 AM | Vivos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/16/2023
3:45 PM | Vivos Therapeutics (Filer)
| Form PRE 14A | |
08/16/2023
3:30 PM | Vivos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/16/2023
3:16 PM | Vivos Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/14/2023
6:46 PM | Vivos Therapeutics (Filer)
| Form NT 10-Q | |
06/20/2023
8:58 PM | Huntsman Ronald Kirk (Reporting)
Vivos Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2023
5:10 AM | Huntsman Ronald Kirk (Reporting)
Vivos Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
6:15 PM | Huntsman Ronald Kirk (Reporting)
Vivos Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
